Department of Clinical Microbiology, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Clin Infect Dis. 2010 Nov 15;51(10):1192-8. doi: 10.1086/656806. Epub 2010 Oct 7.
Although international policies recommend that blood for transfusion should be screened for transfusion-transmitted infections, malaria screening is not performed in most malaria-endemic countries in sub-Saharan Africa. Our literature review identified 17 relevant studies from the period 1980-2009 and indicated that the median prevalence of malaria among 33,029 blood donors was 10.2% (range, 0.7% in Kenya to 55.0% in Nigeria). Malaria screening methods, including microscopy (used in 16 of 17 studies), are either insensitive or impractical for donor screening in resource-poor countries. Even if a suitable screening method were available, rejection of malaria-positive donors would jeopardize the blood supply. Only 1 study established the prevalence of parasitemia among transfusion recipients. This review highlights the need for more evidence about the clinical impact of transfusion-transmitted malaria to justify the policy of screening for blood for malaria in areas of endemicity and for a critical analysis of the feasibility of implementing such a policy and its effect on blood supply.
虽然国际政策建议对用于输血的血液进行输血传播感染筛查,但在撒哈拉以南非洲的大多数疟疾流行国家,并未对疟疾进行筛查。我们的文献回顾确定了 1980 年至 2009 年期间的 17 项相关研究,表明在 33029 名献血者中,疟疾的中位患病率为 10.2%(范围为肯尼亚的 0.7%至尼日利亚的 55.0%)。疟疾筛查方法,包括显微镜检查(17 项研究中有 16 项使用),对于资源匮乏的国家来说,要么不敏感,要么不适合用于献血者筛查。即使有合适的筛查方法,拒绝疟疾阳性的献血者也会危及血液供应。只有 1 项研究确定了输血接受者中寄生虫血症的患病率。这篇综述强调了需要更多关于输血传播疟疾的临床影响的证据,以证明在流行地区筛查疟疾血液的政策的合理性,并对实施这种政策的可行性及其对血液供应的影响进行批判性分析。